A Veteran’s Guide to Qualifying for Ketamine Treatment at the VA
Last reviewed and updated: June 23, 2026.
Key Takeaways
| Spravato at VA | Available via formulary exception for TRD (failed 2+ antidepressants); ask your VA mental health provider specifically; availability varies by VAMC |
| Community Care Network | CCN can refer veterans to outside ketamine clinics at VA expense if VA can’t provide care within 20/28-day wait time window |
| PTSD | Not an FDA-approved Spravato indication, but co-occurring TRD + PTSD strengthens access case; VA PTSD ketamine research active at select sites |
| Documentation to bring | Records of antidepressant trials, symptom severity scores (PHQ-9, PCL-5), therapy history, civilian provider notes, specific ask for Spravato exception or CCN referral |
| If denied | Appeal (consult VSO); request CCN referral; private clinic with veteran discount; Heroic Hearts Project / Mission Within; clinicaltrials.gov |
Ketamine treatment offers a new avenue for veterans grappling with treatment-resistant depression, but qualifying for this therapy requires understanding specific criteria and procedures. Here’s a Veteran’s Guide to Qualifying for Ketamine Treatment at VA facilities.
And if you are having trouble receiving treatment, many ketamine clinics offer large discounts to veterans.
Why Ketamine?
Ketamine, an FDA-approved treatment for treatment-resistant depression, offers a significant benefit to veterans struggling with this condition. Its mechanism, targeting NMDA receptors in the brain, differs from traditional antidepressants, allowing for rapid mood and cognitive improvements, often noticeable within hours or days. This quick action is especially crucial for veterans experiencing severe depressive symptoms, including suicidal thoughts. While not a permanent solution, ketamine provides temporary relief, creating an opportunity for other long-term therapeutic strategies and support to be more effective.
RELATED: VA Accelerates MDMA-Assisted Therapy for Veterans Amidst Escalating Suicide Crisis
Qualification Criteria for Veterans
- Diagnosis: You must have a current diagnosis of unipolar major depressive disorder (MDD).
- Treatment History: A full response to four adequate therapeutic trials of antidepressants or psychotherapy must have failed.
- Severity of Condition: Severe suicidal depression requiring rapid onset of treatment may qualify.
- Evaluation: A VA psychiatrist or a licensed VA healthcare provider must assess and document your eligibility.
- Depression Severity Score: A score of 15 or greater on the Patient Health Questionnaire-9 (PHQ-9) or other similar scales.
Disqualifying Factors
- Mental Health Conditions: Current or past history of schizophrenia, schizoaffective disorder, or bipolar disorder.
- Other Health Issues: Dementia, recent delirium, uncontrolled hypertension, severe cardiac decompensation, or pregnancy.
- Substance Abuse: Positive drug screen or history of ketamine abuse. Note: patients on prescribed opioids, benzodiazepines, or barbiturates are eligible but advised of prolonged recovery.
RELATED: Ketamine vs MDMA for PTSD
Here are the Steps to Receive Treatment
- Screening: Undertake a screening no more than 30 days before the first dose. This includes a psychiatric examination, PHQ-9, cognitive status evaluation, and physical examination.
- Referral: Your VA healthcare provider will refer you for ketamine treatment if you meet the criteria.
- Consent: You must provide verbal informed consent, acknowledging the off-label use of ketamine for depression.
- Preparation for Treatment: Before receiving ketamine, undergo necessary physical and mental health examinations.
For the complete breakdown, download this file from the VA.
RELATED: Study: Psychedelics Have A More Profound Effect on Older Adults
Related reading:
Related: Cleveland Clinic: Ketamine Shows Promise to Treat Suicidal Depression
See also: — related HealingMaps coverage.
See also: — our ketamine therapy resources.
Ketamine at the VA in 2025: What Veterans Need to Know
Access to ketamine therapy through the VA system has expanded since 2022. Here is the current state of VA ketamine access, what to ask your provider, and what options exist if the VA doesn’t meet your needs.
VA formulary status for esketamine (Spravato). Esketamine (Spravato), the FDA-approved nasal spray form of ketamine for treatment-resistant depression (TRD), is available through the VA formulary. The VA added esketamine as a non-formulary option available by exception request in 2021, and access has expanded. Veterans with a documented diagnosis of treatment-resistant depression (typically defined as failing two adequate antidepressant trials) may be eligible to receive Spravato through VA mental health services. This is distinct from IV ketamine infusion — the VA does not typically provide off-label IV ketamine at most facilities, but Spravato, with its FDA approval, can be ordered within the VA system. Availability varies by VAMC location and individual facility formulary decisions.
Community Care Network (CCN): accessing outside ketamine providers. If your local VA does not offer ketamine or Spravato, the VA Community Care Network (CCN) may allow you to be referred to outside ketamine providers at VA expense. CCN eligibility requires meeting one of several criteria: the VA cannot provide the care within a certain wait time (20 days for primary care/mental health, 28 days for specialty care); the VA facility is more than a certain distance from your residence; or the VA determines that a community provider would provide a better outcome. For veterans in rural areas or near VAMCs without mental health ketamine capability, CCN referral is potentially the most practical pathway to accessed ketamine therapy with VA coverage. Work with your VA primary care or mental health provider to initiate a CCN referral request.
PTSD and ketamine: why this matters for veterans. PTSD is one of the most common and debilitating conditions affecting veterans, and conventional first-line treatments (SSRIs, therapy) leave a significant proportion of patients without adequate relief. Ketamine — and particularly ketamine combined with psychotherapy (KAP) — has shown meaningful evidence for PTSD symptom reduction in research, including in veteran populations. The VA has been conducting research on ketamine for PTSD, and access through clinical trials or expanded protocols is increasingly available at major VAMCs. If depression and PTSD are co-occurring (as they frequently are), the combination may strengthen the case for ketamine access through the VA. Discuss both diagnoses with your VA mental health provider when advocating for ketamine access.
What to bring to your VA appointment to advocate for ketamine access. If you are trying to access ketamine through the VA, documentation strengthens your case: (1) Records of prior antidepressant trials — medications tried, doses, durations, and reasons for discontinuation (documenting “treatment-resistant” status). (2) Current symptom severity scores if available (PHQ-9 for depression, PCL-5 for PTSD). (3) Documentation of any prior treatment with therapy, including number of sessions and response. (4) Any civilian provider notes supporting a TRD or PTSD diagnosis. (5) A specific ask: request evaluation for Spravato under the VA formulary exception process, or request a Community Care referral if your VAMC does not offer ketamine.
Frequently Asked Questions
Does the VA cover ketamine for depression?
The VA covers esketamine (Spravato) for treatment-resistant depression (TRD) through its formulary exception process. Veterans who have failed two adequate antidepressant trials and meet TRD diagnostic criteria may be eligible. The process typically involves a VA psychiatrist request and formulary exception approval. IV ketamine infusions are generally not covered by the VA (off-label and not FDA-approved for depression), but Spravato is FDA-approved and is available through the VA in a growing number of facilities. Availability varies by VAMC — call your facility’s mental health department specifically to ask about Spravato availability and the exception process.
Can the VA refer veterans to outside ketamine clinics?
Yes — through the VA Community Care Network (CCN), veterans may be referred to outside community providers for mental health services, including ketamine therapy, when the VA cannot provide the care in a timely manner or within a reasonable distance. CCN eligibility requires documentation that the VA facility either has a wait time exceeding 20 days (primary care/mental health) or 28 days (specialty care), or that a community provider would provide a better outcome for your specific condition. If your local VAMC does not offer ketamine, ask your VA primary care or mental health provider to initiate a CCN referral. Approved CCN referrals cover the cost of community care; you do not pay out of pocket for covered services.
What conditions qualify veterans for ketamine at the VA?
Treatment-resistant depression (TRD) is the primary diagnosis used for Spravato access at the VA — defined as failing two or more adequate antidepressant trials. Major depressive disorder with active suicidal ideation is a second FDA-approved indication for Spravato. PTSD is not currently an FDA-approved indication for esketamine, but co-occurring PTSD and TRD can strengthen the case for access. VA research programs on ketamine for PTSD are active at select sites; veterans interested in research participation can search clinicaltrials.gov or ask their VA provider about active studies. Off-label IV ketamine for chronic pain or PTSD without TRD is generally not accessible through the VA system at most facilities.
What if the VA denies my ketamine request?
If the VA denies ketamine access, several options remain: (1) Appeal the denial — VA benefit denials can be appealed; consult a VA-accredited claims agent or Veterans Service Organization (VSO) for help with the appeal process. (2) Request a CCN referral — if one pathway is denied, specifically ask about Community Care Network referral to a civilian provider. (3) Vet Center and PTSD programs — VA Vet Centers and specialized PTSD programs may have different treatment protocols; ask if ketamine research or expanded access programs are available at your regional VA. (4) Private options — many veterans access ketamine therapy at private clinics at their own expense; some private clinics offer veteran discounts. Organizations like the Heroic Hearts Project and Mission Within provide psychedelic therapy funding and resources for veterans. (5) Clinical trials — search clinicaltrials.gov for ketamine or MDMA/PTSD trials enrolling veterans.
